Wantke F, Proud D, Siekierski E, Kagey-Sobotka A
Johns Hopkins University, School of Medicine, Johns Hopkins Asthma & Allergy Center, Division of Clinical Immunology, Baltimore, MD 21224, USA.
Inflamm Res. 1998 Oct;47(10):396-400. doi: 10.1007/s000110050350.
Histamine in food has been shown to induce intolerance reactions mimicking food allergy. These reactions seem to be due to impaired histamine metabolism caused by reduced diamine oxidase activity. To validate routine serum diamine oxidase assessment, daily variations of diamine oxidase were evaluated.
Blood was drawn from each of 20 healthy volunteers (10 female, 10 male; mean age 32.5 years) every 2 h from 9 a.m. to 5 p.m., and diamine oxidase activity was measured using the C14 putrescine method. To assess possible influences of H1 and H2 blockers on diamine oxidase activity, diphenhydramine, ketotifen, cimetidine, and ranitidine were incubated at pharmacologic concentrations with human placental diamine oxidase (identical to neutrophilic and eosinophilic diamine oxidase). Inhibition of diamine oxidase activity was calculated as the percentage of inhibition versus control. In addition, the known diamine oxidase inhibitors, dihydralazine and aminoguanidine, were used as positive controls.
Serum diamine oxidase levels showed no significant daily variations (0.041 +/- 0.025; 0.037 +/- 0.022; 0.041 +/- 0.023; 0.040 +/- 0.023; 0.038 +/- 0.025 nKat/l) and no significant sex differences (female 0.040 +/- 0.028 nKat/l versus male 0.039 +/- 0.019 nKat/l). Antihistamines had no influence on diamine oxidase activity except for cimetidine, which caused 25% inhibition at the highest dose tested ( p < 0.0002) (positive control: aminoguanidine 85% inhibition (p< 0.0001), dihydralazine 68% inhibition (p<0.0001)) and diphenhydramine, which caused 19% increase (p<0.0001) of enzyme activity.
Serum diamine oxidase levels do not show daily variations allowing assessment anytime during office hours. However, diagnostic interpretation of serum diamine oxidase levels may be difficult.
食物中的组胺已被证明可引发类似食物过敏的不耐受反应。这些反应似乎是由于二胺氧化酶活性降低导致组胺代谢受损所致。为验证血清二胺氧化酶的常规评估方法,对二胺氧化酶的每日变化进行了评估。
从20名健康志愿者(10名女性,10名男性;平均年龄32.5岁)中,于上午9点至下午5点每隔2小时采集一次血液,采用C14腐胺法测定二胺氧化酶活性。为评估H1和H2阻滞剂对二胺氧化酶活性的可能影响,将苯海拉明、酮替芬、西咪替丁和雷尼替丁以药理浓度与人胎盘二胺氧化酶(与嗜中性和嗜酸性二胺氧化酶相同)一起孵育。二胺氧化酶活性的抑制率以相对于对照的抑制百分比计算。此外,已知的二胺氧化酶抑制剂肼屈嗪和氨基胍用作阳性对照。
血清二胺氧化酶水平无明显每日变化(0.041±0.025;0.037±0.022;0.041±0.023;0.040±0.023;0.038±0.025 nKat/l),且无明显性别差异(女性0.040±0.028 nKat/l,男性0.039±0.019 nKat/l)。除西咪替丁外,抗组胺药对二胺氧化酶活性无影响,西咪替丁在最高测试剂量下导致25%的抑制(p<0.0002)(阳性对照:氨基胍85%抑制(p<0.0001),肼屈嗪68%抑制(p<0.0001)),而苯海拉明导致酶活性增加19%(p<0.0001)。
血清二胺氧化酶水平无每日变化,可在办公时间内随时进行评估。然而,血清二胺氧化酶水平的诊断解读可能存在困难。